{"news_desk": "National", "print_page": "21", "section_name": "U.S.", "subsection_name": "Politics", "byline": {"contributor": "", "original": "By SABRINA TAVERNISE", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}]}, "abstract": "House will take up vote on bill that sets aside $10 billion over five years for National Institutes of Health and some half a billion dollars for the FDA in effort to hasten approval of drugs and medical devices.", "type_of_material": "Brief", "word_count": "125", "lead_paragraph": "A bill in the House of Representatives includes rare funding increases that its sponsors say will help carry out the sweeping legislation and spur biomedical innovation.", "pub_date": "2015-05-22T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "More Money Considered for Health Agencies", "content_kicker": "National Briefing", "print_headline": "Washington; More Money Considered for Health Agencies"}, "snippet": "A bill in the House of Representatives includes rare funding increases that its sponsors say will help carry out the sweeping legislation and spur biomedical innovation.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/05/22/us/politics/more-money-considered-for-health-agencies.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "National Institutes of Health", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Medical Devices", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Federal Budget (US)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Law and Legislation", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "House of Representatives", "name": "organizations"}], "blog": [], "_id": "555e8a8338f0d86bef1f6673", "source": "The New York Times"}